The NfL protein values were overall not significantly decreased between baseline values and after a different number of nusinersen doses (H test = 9.67; df = 13; p = 0.72; Figure 3) in all SMA patients. This evidence concerns the gene NEFL and proximal spinal muscular atrophy.